Fmoc/tBu solid-phase peptide synthesis — resin loading, deprotection, activation/coupling, and cleavage, tracked cycle by cycle with Kaiser test readouts and deletion-sequence accumulation
Every Fmoc/tBu solid-phase synthesis begins by covalently attaching the C-terminal amino acid to an insoluble polymeric support — cross-linked polystyrene (1% divinylbenzene) or a PEG-polystyrene composite such as ChemMatrix or TentaGel. The choice of resin, linker chemistry, and initial substitution level shapes every subsequent coupling and ultimately determines whether a 30-mer difficult sequence is even synthetically accessible.
Resin selection is the first design decision in any SPPS campaign, and it fixes both the C-terminal functional group of the final peptide and the swelling behavior that governs reagent diffusion throughout the synthesis:
Support polymers: • Polystyrene 1% DVB (Merrifield-type): classic, inexpensive, swells well in DCM/DMF/NMP; poor in water and protic solvents • PEG-PS composites (ChemMatrix, TentaGel, NovaPEG): PEG spacer arms improve solvation in a broader solvent range and reduce peptide chain aggregation — preferred for long or aggregation-prone sequences (>25 residues) • Polystyrene-PEG hybrids swell 4–8 mL/g in DMF vs. ~4 mL/g for plain polystyrene
Linker/handle chemistry (defines the C-terminus): • Wang resin (p-alkoxybenzyl alcohol): esterified to Fmoc-AA-OH via DIC/DMAP or the amino acid symmetric anhydride → cleaved by TFA to give a free C-terminal carboxylic acid • Rink amide MBHA / Rink amide AM: gives a C-terminal primary carboxamide on TFA cleavage — the most common choice for bioactive peptide mimics • 2-Chlorotrityl chloride (2-CTC) resin: extremely acid-labile (cleaves with 1% TFA/DCM or even AcOH/TFE), permits fully protected peptide fragment release for fragment condensation strategies; also minimizes racemization at the first residue because loading proceeds without strong base • HMPB-linker: acid-labile handle for depsipeptides and hydroxyl-bearing C-termini
Loading protocol and quantification: • First residue coupling: Fmoc-AA-OH (2.5–4 eq) activated as symmetric anhydride or with DIC/DMAP (Wang) or simply DIPEA (Rink amide, pre-functionalized) for 1–16 h • Unreacted resin sites capped with acetic anhydride/DIPEA or benzoyl chloride to prevent later spurious coupling to bare linker • Substitution determined by Fmoc-UV assay: a weighed resin aliquot treated with 20% piperidine/DMF releases the dibenzofulvene-piperidine adduct, quantified spectrophotometrically at 301 nm (ε=7800 M⁻¹cm⁻¹); loading (mmol/g) = (A₃₀₁ × dilution volume) / (7800 × resin mass) • Target loading for long/difficult sequences deliberately kept low (0.15–0.35 mmol/g) — lower site density on the bead surface reduces inter-chain aggregation (β-sheet formation between adjacent growing peptide chains) that otherwise causes incomplete Fmoc deprotection and coupling failures from residue ~15 onward
Before any new residue can be coupled, the Fmoc (9-fluorenylmethyloxycarbonyl) carbamate protecting the α-amine of the resin-bound chain must be removed. This is achieved with a secondary amine base — almost universally 20% piperidine in DMF — through a base-mediated E1cb elimination that is fast, essentially quantitative, and orthogonal to the acid-labile side-chain protecting groups used throughout the rest of the synthesis.
Fmoc removal proceeds by a two-step E1cb (elimination, unimolecular conjugate base) mechanism exploiting the acidity of the fluorenyl C9-H:
Mechanism: 1. Piperidine (pKaH ≈ 11.1) abstracts the acidic proton at the fluorenyl 9-position, generating a highly stabilized cyclopentadienyl-type carbanion delocalized into both benzo rings 2. The carbanion collapses, expelling a carbamate anion which spontaneously decarboxylates (loses CO₂) to unmask the free primary α-amine 3. The resulting dibenzofulvene (DBF) is highly electrophilic and is scavenged in situ by a second equivalent of piperidine via aza-Michael addition, forming the stable 1-(9H-fluoren-9-ylmethyl)piperidine adduct — this adduct, not free DBF, is what accumulates in the deprotection filtrate
Standard protocol: • 20% v/v piperidine in DMF, two treatments of 3–10 min each (short first wash clears bulk Fmoc, longer second wash drives completion) • Reaction is essentially instantaneous for solvent-accessible, non-aggregated chains (t½ <10 s) but can slow dramatically (minutes) in aggregated, β-sheet-forming sequence stretches • Alternative deprotection cocktails: 5% piperazine/DBU in NMP or 4-methylpiperidine/DMF, used when the peptide sequence contains base-sensitive residues (e.g., Asp-Gly, prone to aspartimide formation under prolonged strong-base exposure) or when synthesizing on automated flow instruments where lower-viscosity, lower-odor reagents are preferred
On-line UV monitoring: • Automated synthesizers (e.g., continuous-flow instruments) monitor the deprotection filtrate absorbance in real time at 301 nm (and a secondary peak at 267 nm) • Absorbance trace shows a sharp rise then plateau to baseline; the area under the curve is proportional to moles of Fmoc removed, giving a real-time, per-cycle deprotection efficiency readout without any manual sampling • A truncated or unusually broad deprotection peak flags aggregation or a sterically hindered residue (e.g., after multiple consecutive β-branched residues like Val-Ile-Thr) — an early warning to extend deprotection time or add a chaotropic co-solvent
Coupling is the chemical heart of SPPS: the carboxylic acid of the next Fmoc-amino acid must be activated into an electrophilic species reactive enough to acylate the resin-bound amine within minutes, yet controlled enough to avoid racemization at the activated stereocenter. Modern uronium/aminium and phosphonium reagents routinely push single-step coupling yields above 99.5%, but that residual 0.5% failure compounds catastrophically over a long sequence if left unchecked.
Coupling reagents convert the free carboxylic acid of the incoming Fmoc-amino acid into a reactive acylating species in situ:
Activation chemistries: • Uronium/aminium salts — HBTU, TBTU, HATU: react with the carboxylate and a base (DIPEA, 2–4 eq) to form an O-acyluronium intermediate that rapidly rearranges to an OBt/OAt active ester; HATU (7-aza analog) gives faster kinetics and lower racemization via intramolecular base catalysis from the triazine nitrogen • Phosphonium salts — PyBOP, PyAOP: mechanistically similar active-ester formation, historically favored for hindered couplings • Carbodiimide/additive pairs — DIC with Oxyma Pure (ethyl cyanohydroxyiminoacetate) or HOBt: forms an O-acylisourea trapped as an OXm/OBt active ester; DIC/Oxyma is now preferred industrially because it avoids the explosive-hazard classification of HOBt/HOAt and gives very low racemization (<0.1%) even for cysteine and histidine
Typical coupling protocol: • 3–5 eq activated Fmoc-amino acid relative to resin amine loading, in DMF or NMP, 30–90 min at room temperature (or 50–90°C microwave-assisted for hindered/aggregating couplings, completing in 5–10 min) • Double or triple coupling routinely applied at known difficult positions (after Pro, Val, Ile, or within predicted β-sheet-forming stretches)
Reaction monitoring — the Kaiser (ninhydrin) test: • A small resin sample is treated with ninhydrin/phenol/KCN-pyridine reagent and heated to 100°C for ~5 min • Free primary amines (unreacted resin sites) react with ninhydrin to form Ruhemann's purple, turning both beads and solution deep blue — a positive (blue) test after a coupling step means the reaction is incomplete and must be repeated or extended • A negative test (beads remain colorless/pale yellow) indicates >99% of amine sites have acylated, clearing the cycle to proceed to the next Fmoc deprotection • Limitation: the Kaiser test is unreliable for secondary amines (proline, N-methylated residues) since they do not form the purple chromophore — the chloranil test (2,3,5,6-tetrachloro-1,4-benzoquinone) is substituted at those positions • Quantitative variant: absorbance of the Kaiser filtrate at 570 nm can be converted to a residual free-amine concentration, giving a numerical coupling efficiency rather than a qualitative pass/fail
A 20-residue peptide requires roughly 40 chemical operations (20 deprotections + 20 couplings) performed on the very same solid support, and the overall crude purity is essentially the per-step coupling efficiency raised to the power of the chain length. Even a coupling efficiency universally regarded as excellent — 99.5% per step — yields only ~90% theoretical full-length product after 20 residues, and the gap is filled almost entirely by (n−1) and (n−2) deletion peptides that are notoriously difficult to separate from the target by standard RP-HPLC.
Overall crude yield in SPPS follows simple multiplicative kinetics: if each of N coupling steps proceeds with average efficiency e, the fraction of resin-bound chains that are full-length target sequence is e^N. This exponential relationship is the central design constraint of every SPPS campaign:
Cumulative yield vs. per-step efficiency (N=20 residues): • e = 99.9% → 98.0% full-length • e = 99.5% → 90.5% full-length • e = 99.0% → 81.8% full-length • e = 98.0% → 66.8% full-length • e = 95.0% → 35.8% full-length — essentially unsynthesizable without heroic purification
For a 40-residue peptide the same 99% per-step efficiency collapses to 66.9% full-length product, illustrating why long or aggregation-prone sequences (>40–50 residues) typically shift to native chemical ligation of shorter SPPS-made fragments rather than single continuous chain assembly.
Deletion sequences and why capping matters: • If a coupling fails at cycle k, the unreacted free amine on that subset of resin beads remains nucleophilic and — without intervention — will react in cycle k+1 with the NEXT amino acid instead, producing an (n−1) deletion peptide missing exactly one internal residue • (n−1) deletion peptides are pernicious because they differ from the target by only one residue's mass and often co-elute on standard C18 gradients, requiring orthogonal purification (ion-exchange, or a shallower analytical gradient) to resolve • Capping intervention: after every coupling step (regardless of Kaiser result on production-scale synthesis), residual free amines are acetylated with acetic anhydride/pyridine or acetic anhydride/DIPEA/HOBt, 5–10 min • Once capped, that truncated chain can never react again — it remains a short, N-terminally acetylated truncate for the rest of the synthesis, which differs from the target by a large mass and is trivially separated by RP-HPLC • Net effect of capping: converts what would have been a hard-to-remove near-full-length deletion contaminant into an easy-to-remove short truncate, at the cost of an irrecoverable loss of that fraction of resin-bound material
A published case study on a 31-residue therapeutic peptide analog reported an average measured coupling efficiency of 99.4% per step across the synthesis. Without capping, LC-MS of the crude product showed >15 distinct deletion species spanning a 2 kDa mass envelope, several co-eluting within 0.3 min of the target on a standard 20 min C18 gradient. After introducing a mandatory acetic anhydride capping step following every coupling, the number of resolvable deletion peaks dropped to 4, all well-separated (>1.5 min) from the target peak, and preparative HPLC recovery of pure full-length material rose from 21% to 38% of crude mass.
Once the final residue is coupled and its N-terminal Fmoc removed (or capped, for a blocked N-terminus), the assembled, fully side-chain-protected peptide must be released from the solid support and stripped of every tBu-, Boc-, Trt-, and Pbf-type protecting group in a single acidolysis step. This is where all of the preceding chemistry either pays off — or where a rare side reaction (tBu cation alkylation, Asp/Gln cyclization, oxidation of Cys/Met/Trp) can destroy an otherwise perfect synthesis in the final hour.
Global deprotection and cleavage exploit the orthogonality between the base-labile Fmoc group (already removed cycle-by-cycle) and the acid-labile side-chain protecting groups and resin linker, all cleaved together by concentrated trifluoroacetic acid:
Standard cleavage cocktail (Reagent K family): • TFA:triisopropylsilane (TIS):H₂O = 95:2.5:2.5 (v/v/v), 2–3 h at room temperature, ~10 mL per gram resin • TIS and water act as cation scavengers, intercepting the tert-butyl and trityl cations liberated during deprotection before they can re-alkylate electron-rich side chains (Trp indole, Tyr phenol, Met thioether) • For Cys-, Met-, or Trp-containing sequences: ethanedithiol (EDT, 2.5%) or thioanisole added to the cocktail as a softer, more nucleophilic scavenger — critical for prevention of Cys S-alkylation and Trp oxidation • Boc-protected Arg(Pbf) and His(Trt) require the full 2–3 h treatment for complete Pbf/Trt removal; premature quenching leaves partially protected side products visible as +Δm satellite peaks by MS
Precipitation and initial workup: • The TFA cleavage solution is filtered from the spent resin and added dropwise to 10 volumes of ice-cold diethyl ether, precipitating the peptide TFA salt while scavengers and cleaved protecting-group cations remain in solution • Pellet collected by centrifugation, washed 2–3× with fresh cold ether to remove residual scavenger odor and cations, then dried under vacuum or lyophilized from aqueous acetonitrile
Purification and analysis: • Analytical RP-HPLC (C18, 2.1–4.6 mm column, 0.1% TFA/water–acetonitrile gradient, UV 220 nm) assesses crude purity — typically 40–75% for a well-optimized 15–25 residue peptide, lower for longer or more hydrophobic/aggregating sequences • Preparative RP-HPLC (C18, larger particle/pore size, shallow gradient ~0.5–1% ACN/min) isolates the target mass; fractions pooled by purity (>95% typically required for research-grade peptide, >99% for GMP/clinical material) and lyophilized to a stable powder • Final identity confirmed by ESI-MS (multiply charged envelope, deconvoluted) or MALDI-TOF (singly charged [M+H]⁺); observed monoisotopic or average mass compared to theoretical within <0.1% error • Common failure signatures on MS: −18 Da (dehydration/cyclization), +14 Da ladders (incomplete deprotection or O→N acyl shift), −1 Da doublets (aspartimide formation at Asp-Gly/Asp-Ser motifs) — each pointing back to a specific step in the synthesis that requires re-optimization